Results 211 to 220 of about 54,406 (266)

A Scoping Review of Influences on HPV Vaccine Uptake in the Rural US. [PDF]

Vaccines (Basel)
Sheinfeld Gorin S, Hyman R, Olson C, Fournier EA, Yang K, Hanko D, Hpv Review Working Group.   +6 more
europepmc   +1 more source

Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study. [PDF]

PLoS Med
Carvalho N, Watts E, Oliver VL, Clark A, Ozturk MH, Akauola S, Whelan C, Naseri T, Jenkins K, Mikkelsen-Lopez I, Lam KFK, Rabanal R, McLeod R, Jit M, Russell FM.   +14 more
europepmc   +1 more source

Human Papillomavirus vaccine knowledge and recommendation practice among primary care providers, Almaty, Kazakhstan - 2023. [PDF]

Hum Vaccin Immunother
Ablimitova F, Nabirova D, Gazezova S, Smagul M, Kuatbaeva A, Yesmagambetova A, Millman AJ, Horth R.   +7 more
europepmc   +1 more source

Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations. [PDF]

J Gynecol Oncol
Lim H, Kim SI, Min KJ, Lee JK, Kim JW, Lee TS.   +5 more
europepmc   +1 more source

Economic evaluation of 22 HPV vaccination strategies to minimize the risk of penile, anal, and oropharyngeal cancers in Chinese males: A Markov model analysis. [PDF]

Hum Vaccin Immunother
Wang D, Luo W, Qin R, Xu G, Chai P, Liu B, Zhou L, Zhang X.   +7 more
europepmc   +1 more source

HPV vaccination in Iran: expert perspectives on family dynamics and barriers. [PDF]

BMC Womens Health
Faghir-Ganji M, Feizabadi P, Ansari-Moghaddam A, Abdolmohammadi N, Eshrati B.   +4 more
europepmc   +1 more source

A Questionnaire Survey on Human Papillomavirus Vaccination Among Hospital-Based Healthcare Professionals. [PDF]

Yonago Acta Med
Kimura A, Oishi T, Fujioka R, Tashiro W, Takahashi M, Kigawa J, Irie T.   +6 more
europepmc   +1 more source

Nursing students' knowledge and attitudes toward human papillomavirus vaccination and infection. [PDF]

Hum Vaccin Immunother
Mabrouk Nouh F, Abualruz H, Al-Zoubi M, Al-Mugheed K, Ahmed Shahin HE, Ezzat El-Gobashy R, Sh Abdullah AI, Alasser AMF, Al Hrinat J, Ghaleb Hendi A, Soliman Ashour ES, Baghdadi NA, Farghaly Abdelaliem SM, Khalifa Khalil A.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prophylactic papillomavirus vaccines

Clinics in Dermatology, 2014
Human papillomaviruses (HPV) are the causative agents of cervical cancer, the third most common cancer in women. The development of prophylactic HPV vaccines Gardasil® and Cervarix® targeting the major oncogenic HPV types is now the frontline of cervical cancer prevention.
Lis, Ribeiro-Müller, Martin, Müller
openaire   +2 more sources

Human Papillomavirus Vaccines

Clinical Obstetrics & Gynecology, 2023
Human papillomavirus (HPV) vaccines are highly effective in preventing the transmission of HPV and thus downstream HPV-related lower genital tract neoplasias. First introduced in 2006, the HPV vaccine has demonstrated clinical efficacy in both men and women.
openaire   +2 more sources